UY36688A - Compuestos de imidazotriazina - Google Patents
Compuestos de imidazotriazinaInfo
- Publication number
- UY36688A UY36688A UY0001036688A UY36688A UY36688A UY 36688 A UY36688 A UY 36688A UY 0001036688 A UY0001036688 A UY 0001036688A UY 36688 A UY36688 A UY 36688A UY 36688 A UY36688 A UY 36688A
- Authority
- UY
- Uruguay
- Prior art keywords
- compound
- leishmaniasis
- imidazotriazine compounds
- imidazotriazine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un compuesto de Formula (I), o una de sus sales, composiciones que comprenden el compuesto, procedimientos para su preparación y su uso en terapia, por ejemplo, en el tratamiento de enfermedades parasitarias tales como enfermedad de Chagas, tripanosomiasis africana humana (HAT) y leishmaniasis, particularmente leishmaniasis visceral (VL).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15382283 | 2015-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36688A true UY36688A (es) | 2016-12-30 |
Family
ID=53398015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036688A UY36688A (es) | 2015-05-29 | 2016-05-27 | Compuestos de imidazotriazina |
Country Status (14)
Country | Link |
---|---|
US (1) | US10065965B2 (es) |
EP (1) | EP3303336A1 (es) |
JP (1) | JP2018516265A (es) |
CN (1) | CN107922419A (es) |
AR (1) | AR104749A1 (es) |
AU (1) | AU2016269626B2 (es) |
BR (1) | BR112017025668A2 (es) |
CA (1) | CA2987329A1 (es) |
CL (1) | CL2017003025A1 (es) |
CO (1) | CO2017011969A2 (es) |
CR (1) | CR20170546A (es) |
TW (1) | TW201713661A (es) |
UY (1) | UY36688A (es) |
WO (1) | WO2016193111A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017127627A1 (en) | 2016-01-21 | 2017-07-27 | The University Of North Carolina At Chapel Hill | Compounds for treatment of trypanosomes and neurological pathogens and uses thereof |
JOP20190278A1 (ar) * | 2017-05-31 | 2019-11-28 | Novartis Ag | مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية |
EA039324B1 (ru) * | 2017-11-06 | 2022-01-13 | Новартис Аг | 5,6–конденсированные бициклические соединения и композиции для лечения паразитарных заболеваний |
CN108129409B (zh) * | 2018-01-22 | 2020-07-03 | 三金集团湖南三金制药有限责任公司 | 一种改进的合成拉莫三嗪的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010151799A2 (en) * | 2009-06-26 | 2010-12-29 | University Of Massachusetts | Compounds for modulating rna binding proteins and uses therefor |
UY35400A (es) | 2013-03-15 | 2014-10-31 | Novartis Ag | Compuestos y composiciones para el tratamiento de enfermedades parasitarias |
US9233961B2 (en) * | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
MA39186A1 (fr) | 2013-12-19 | 2017-11-30 | Novartis Ag | Dérivés de [1,2,4]triazolo[1,5-a]pyrimidine utilisés comme inhibiteurs du protéasome des protozoaires pour le traitement de maladies parasitaires comme la leishmaniose |
-
2016
- 2016-05-26 AU AU2016269626A patent/AU2016269626B2/en not_active Ceased
- 2016-05-26 EP EP16724912.7A patent/EP3303336A1/en not_active Withdrawn
- 2016-05-26 BR BR112017025668A patent/BR112017025668A2/pt not_active Application Discontinuation
- 2016-05-26 CR CR20170546A patent/CR20170546A/es unknown
- 2016-05-26 JP JP2017561909A patent/JP2018516265A/ja active Pending
- 2016-05-26 US US15/575,032 patent/US10065965B2/en not_active Expired - Fee Related
- 2016-05-26 AR ARP160101518A patent/AR104749A1/es unknown
- 2016-05-26 WO PCT/EP2016/061887 patent/WO2016193111A1/en active Application Filing
- 2016-05-26 CA CA2987329A patent/CA2987329A1/en not_active Abandoned
- 2016-05-26 CN CN201680031400.6A patent/CN107922419A/zh active Pending
- 2016-05-26 TW TW105116384A patent/TW201713661A/zh unknown
- 2016-05-27 UY UY0001036688A patent/UY36688A/es unknown
-
2017
- 2017-11-24 CO CONC2017/0011969A patent/CO2017011969A2/es unknown
- 2017-11-28 CL CL2017003025A patent/CL2017003025A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR104749A1 (es) | 2017-08-09 |
US20180141949A1 (en) | 2018-05-24 |
US10065965B2 (en) | 2018-09-04 |
TW201713661A (zh) | 2017-04-16 |
CL2017003025A1 (es) | 2018-03-16 |
CN107922419A (zh) | 2018-04-17 |
AU2016269626B2 (en) | 2019-05-30 |
JP2018516265A (ja) | 2018-06-21 |
CO2017011969A2 (es) | 2018-02-09 |
CR20170546A (es) | 2018-04-02 |
AU2016269626A1 (en) | 2017-12-14 |
CA2987329A1 (en) | 2016-12-08 |
BR112017025668A2 (pt) | 2018-08-07 |
WO2016193111A1 (en) | 2016-12-08 |
EP3303336A1 (en) | 2018-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2016000271A (es) | Compuestos de heteroarilo o arilo bicíclicos fusionados | |
SV2015005066A (es) | Compuestos de biaril-amida como inhibidores de cinasa | |
CY1118478T1 (el) | Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου | |
UY35400A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
SV2017005405A (es) | Compuestos y composiciones como inhibidores de quinasa raf | |
CU20190101A7 (es) | Imidazopirimidinas diazabicíclicas sustituidas | |
ECSP20046463A (es) | Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas | |
UY36875A (es) | Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades | |
GT201700058A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
CL2019000661A1 (es) | Inhibidores de dopamina–b–hidroxilasa penetrantes de la barrera hematoencefálica. | |
UY36145A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
CY1122077T1 (el) | Νεα δακτυλιωμενα φαινοξυακεταμιδια | |
ECSP19026702A (es) | Compuestos novedosos para el tratamiento de enfermedades parasitarias | |
CL2016001421A1 (es) | Derivados de [1,2,4] triazolo [1,5-a] pirimidina como inhibidores de proteasoma para el tratamiento de enfermedades parasitarias como la leishmaniasis. | |
CY1124151T1 (el) | Ενωσεις | |
CL2017003025A1 (es) | Derivados(1,2-b)(1,2,4)de imidazotriazina como agentes antiparasitarios. | |
CL2017000040A1 (es) | Inhibidores de aldosterona sintasa. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
NI201600091A (es) | UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS | |
DOP2019000021A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
UY37166A (es) | Nucleósidos ánalogos de alquinilo como inhibidores de rinovirus humano | |
DOP2016000325A (es) | Compuestos, composición farmacéutica y su uso en el tratamiento de enfermedades neurodegenerativas | |
TR201906539T4 (tr) | Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi. |